CD4 and CD8 T-cell response is dominated by IL-10–secreting cells in children with uncomplicated Plasmodium falciparum malaria
ImmunoHorizons · 2025
DOI: 10.1093/immhor/vlaf045 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Bonface O Ariera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Technology, Maseno University, Maseno, Kenya. Hauptthemen laut MEDLINE: Malaria, Falciparum, Interleukin-10, CD8-Positive T-Lymphocytes, Plasmodium falciparum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Disease awarded to Dr. Rosemary Rochford.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Plasmodium falciparum malaria and Epstein-Barr virus (EBV) coinfections have been associated with an increased risk of developing the EBV-associated cancer endemic Burkitt lymphoma (eBL). In children living in malaria-endemic areas, repeated episodes of malaria may alter the immune system’s ability to suppress EBV, creating a permissive environment for eBL pathogenesis. However, the malaria-driven mechanisms involved remain undefined, including whether malaria-induced immune alterations are EBV-specific or systemic. To identify whether acute clinical P. falciparum malaria affects EBV T-cell immunity, we characterized T-cell activation status and cytokine secretion profiles using flow cytometry. We compared profiles in 10 Kenyan children with acute clinical P. falciparum malaria at baseline and matched 4-week recovery, and 10 healthy community controls following antigenic stimulation with EBV- and cytomegalovirus-specific peptides. The percentage frequency of activation-induced marker cells was comparable within the study cohort across the different stimulations. Furthermore, we observed a shift in cytokine secretion in children with acute malaria during active disease and at 4 weeks postrecovery, favoring IL-10 for both T-cell subsets. Our findings suggest that clinical malaria did not result in the impairment of T-cell activation, but rather induced shifts in cytokine secretion in favor of IL-10. We further demonstrate that malaria-induced T-cell immune alterations are not EBV-specific but rather affect overall immune suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences and Technology, Maseno University, Maseno, Kenya.
- Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
- Department of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH, United States.
- Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR, United States.
- Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, United States.
ORCID-Profile: Kevin Waomba
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Disease awarded to Dr. Rosemary Rochford
Zitieren
APA
Ariera, B. O., Guyah, B., Onditi, I., Waomba, K., Koech, E., Sabourin, K. R., Samayoa-Reyes, G., Rochford, R., & Ogolla, S. (2025). CD4 and CD8 T-cell response is dominated by IL-10–secreting cells in children with uncomplicated Plasmodium falciparum malaria. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf045
Vancouver
Ariera BO, Guyah B, Onditi I, Waomba K, Koech E, Sabourin KR, et al. CD4 and CD8 T-cell response is dominated by IL-10–secreting cells in children with uncomplicated Plasmodium falciparum malaria. ImmunoHorizons. 2025. doi:10.1093/immhor/vlaf045
BibTeX
@article{Ariera2025,
author = {Ariera, Bonface O and Guyah, Bernard and Onditi, Ian and Waomba, Kevin and Koech, Emily and Sabourin, Katherine R and Samayoa-Reyes, Gabriela and Rochford, Rosemary and Ogolla, Sidney},
title = {CD4 and CD8 T-cell response is dominated by IL-10–secreting cells in children with uncomplicated Plasmodium falciparum malaria},
journal = {ImmunoHorizons},
year = {2025},
doi = {10.1093/immhor/vlaf045}
}
EUVIMED